There are 2789 resources available
74P - A predictive signature for response to immunotherapy in non-small cell lung cancer based on plasma proteomics and clinical parameters
Presenter: Yuval Shaked
Session: ePoster Display
75P - Tumor mutational burden in clinical routine practice: Identifying the right threshold?
Presenter: Célia Dupain
Session: ePoster Display
76P - Analysis of antitumor activity of dostarlimab by tumor mutational burden (TMB) in patients (pts) with endometrial cancer (EC) in the GARNET trial
Presenter: Ana Oaknin
Session: ePoster Display
77P - Identification of prognostic and predictive immunological biomarkers in stage I and III non-small cell lung cancer (NSCLC) patients: A prospective exploratory study
Presenter: Rianne Vaes
Session: ePoster Display
159P - SiMosein, a real-life prospective evaluation of EndoPredict use in early ER-positive, HER2-negative breast cancers
Presenter: Jacqueline Lehmann-Che
Session: ePoster Display
167P - Role of the multi-gene panel testing for detection of pathogenic variants in patients with hereditary bilateral breast cancer
Presenter: Clarissa Filorizzo
Session: ePoster Display
128P - Characteristics, patterns of care and outcomes of young women with breast cancer (BC) according to age, year of diagnosis and germline BRCA status (gBRCA)
Presenter: Kevin Punie
Session: ePoster Display
129P - Integration of gene expression and tumor-infiltrating lymphocytes (TILs) to predict pCR after neoadjuvant chemotherapy and nivolumab for patients with luminal B-like breast cancer in the phase II GIADA trial
Presenter: Maria Vittoria Dieci
Session: ePoster Display
172P - Stage-dependent prognostic value of systemic inflammatory biomarkers in early triple-negative breast cancer (TNBC)
Presenter: Guilherme Nader Marta
Session: ePoster Display